Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
The first of four planned modules at the new plant is expected to come online by summer 2026
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Expands bioprocessing footprint across Asia
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
Indian companies must make their own intermediates and support small industries: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Subscribe To Our Newsletter & Stay Updated
